Gyrus bipolar electrovaporization vs transurethral resection of the prostate: a randomized prospective single-blind trial with 1 y follow-up.
The Gyrus system uses bipolar electrocautery with saline irrigation to vaporize prostatic tissue and is compared to transurethral resection of the prostate (TURP) in a randomized prospective study with 1 y follow-up. Outcomes measured were fluid absorption, blood loss, period of catheterization, hospital stay, symptom scores, quality of life, flow rates, and post-void residual volumes at 3, 6, and 12 months. All measured parameters were similar, although re-catheterization rates were higher (30% vs 5%) in the Gyrus group. Clot evacuation rates were higher in the TURP group (19% vs 0%). The Gyrus device is safe and produces results that are similar to TURP at 1 y.
Dunsmuir
W D
WD
Department of Urology, Monash Medical Centre, Melbourne, Australia. billydunsmuir@btinternet.com
McFarlane
J P
JP
Tan
A
A
Dowling
C
C
Downie
J
J
Kourambas
J
J
Donnellan
S
S
Redgrave
N
N
Fletcher
R
R
Frydenberg
M
M
Love
C
C
D000368:Aged; D004867:Equipment Design; D006801:Humans; D007902:Length of Stay; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications; D011471:Prostatic Neoplasms / Q000601:surgery*; D011788:Quality of Life; D016037:Single-Blind Method; D012965:Sodium Chloride / Q000008:administration & dosage; D007507:Therapeutic Irrigation; D020728:Transurethral Resection of Prostate / Q000379:methods*; D016896:Treatment Outcome; D014546:Urinary Catheterization; D014882:Water-Electrolyte Balance
D012965:Sodium Chloride